Trump denies sleeping during trial: ‘I simply close my beautiful blue eyes’
Donald Trump returned to his criminal hush money trial in New York after Judge Juan Merchan held him in contempt for violating his gag order.
Moderna loses less than expected as Covid vaccine sales beat estimates, cost cuts take hold
The company reiterated its full-year 2024 sales guidance of roughly $4 billion, which includes revenue from the expected launch of its RSV vaccine.
Carvana shares spike 30% as used car retailer posts record first quarter
Carvana reported record first-quarter results Wednesday that beat Wall Street’s top- and bottom-line earnings expectations for the online used car retailer.
Long-predicted consumer pullback finally hits restaurants like Starbucks, KFC and McDonald’s
Starbucks, Pizza Hut and KFC are among the chains that reported same-store sales declines this quarter.
Fed keeps rates steady as it notes ‘lack of further progress’ on inflation
With the decision to hold the line on rates, the committee noted a “lack of further progress” in getting inflation back down to the central bank’s 2% target.
Here’s what changed in the new Fed statement
This is a comparison of Wednesday’s Federal Open Market Committee statement with the one issued after the Fed’s previous policymaking meeting in March.
The Federal Reserve holds interest rates steady, offers no relief from high borrowing costs — what that means for your money
The Federal Reserve pushed out rate-cut expectations — here’s what that means for your credit card, mortgage rate, auto loan and savings account.
Amazon-backed Anthropic launches iPhone app and business tier to compete with OpenAI’s ChatGPT
Anthropic on Wednesday announced its first-ever enterprise offering, as well as its first iOS app.
Why hundreds of U.S. banks may be at risk of failure
Of about 4,000 banks, 282 banks face threats from commercial real estate and higher interest rates, according to a study by Klaros Group.
Pfizer beats earnings estimates, raises outlook on cost cuts and smaller-than-feared drop in Covid drug sales
The pharmaceutical giant’s quarterly results also benefited from a smaller-than-feared drop in sales for its Covid antiviral pill Paxlovid.
